Prostate cancer is a malignancy of one of the major male sex glands, in which cells of the prostate become abnormal and start to grow uncontrollably, forming tumors.
Researchers identify molecular predictor of metastatic prostate cancer — Finding lays the groundwork for gene-based test – Researchers conducted an elaborate series of experiments to identify the genes most closely linked to the aggressive biology of prostate cancer. They found about 300 genes that distinguished the two groups – indolent versus aggressive prostate cancers.
MicroRNA suppresses prostate cancer stem cells and metastasis — UT MD Anderson preclinical research boosts case for new drug approach – A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells, revealed by researchers.
Behavioral therapy program reduces incontinence following radical prostatectomy – For men with incontinence for at least one year following radical prostatectomy, participation in a behavioral training program that included pelvic floor muscle training, bladder control strategies and fluid management, resulted in a significant reduction in the number of incontinence episodes.
Age plays too big a role in prostate cancer treatment decisions – Older men with high-risk prostate cancer frequently are offered fewer ? and less effective ? choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.
UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer – A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy.
Cost of prostate cancer care varies with initial treatment choice – A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives.
Brothers of prostate cancer patients undergo more diagnostic activities – The brothers of men with prostate cancer are at an increased risk of prostate cancer diagnosis because of increased diagnostic activity and not necessarily because they carry a genetic mutation that increases risk of the disease, according to a study published online August 19 in The Journal of the National Cancer Institute.
Dense bones linked to raised risk for prostate cancer – Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging (NIA), part of the National Institutes of Health.
Cancer deaths continue to drop in USA – The continued drop in overall cancer mortality rates over the last 20 years has averted more than three-quarters of a million (767,000) cancer deaths according to a new report from the American Cancer Society.
Statins associated with lower cancer recurrence following prostatectomy – Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also found that higher doses of the drugs were associated with lower risk of recurrence.
Nanoparticle PSA test predicts if prostate cancer will return — Ultrasensitive test gives first accurate answer after prostate cancer surgery – New research from Northwestern University Feinberg School of Medicine and the University International Institute for Nanotechnology shows that an ultrasensitive PSA test using nanoparticle-based technology (VeriSens? PSA, Nanosphere, Inc., research-use-only) may be able to definitively predict after surgery if the cancer is cured long term or if it will recur.
Patients who refuse prostate cancer surgery have worse long-term survival – Men who refuse surgery for prostate cancer and instead opt for “watchful waiting” ? monitoring cancer progression without undergoing treatment ? have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in Detroit.
